Search

Your search keyword '"Kowarik M"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Kowarik M" Remove constraint Author: "Kowarik M"
83 results on '"Kowarik M"'

Search Results

4. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

5. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

6. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

7. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions

9. Long-term safety and efficacy of Eculizumab in Aquaporin-4 IgG-positive NMOSD

11. Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

13. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

14. Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

15. Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data

16. Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data

17. The diversity of Klebsiella pneumoniae surface polysaccharides

29. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB

30. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

31. Reexpansion pulmonary edema following a posttraumatic pneumothorax: a case report and review of the literature

32. Production of glycoprotein vaccines in Escherichia coli

33. The development and characterization of an E. coli O25B bioconjugate vaccine

35. Ultrafast Brain MRI at 3 T for MS: Evaluation of a 51-Second Deep Learning-Enhanced T2-EPI-FLAIR Sequence.

36. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial.

37. Machine learning algorithms predict canine structural epilepsy with high accuracy.

38. Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial.

39. Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outline.

40. Identification of a second glycoform of the clinically prevalent O1 antigen from Klebsiella pneumoniae .

41. No evidence of oligoclonal bands, intrathecal immunoglobulin synthesis and B cell recruitment in acute ischemic stroke.

42. Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: A case report (part II).

43. Structured Reporting in Multiple Sclerosis - Consensus-Based Reporting Templates for Magnetic Resonance Imaging of the Brain and Spinal Cord.

44. The development and characterization of an E. coli O25B bioconjugate vaccine.

45. Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.

47. Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate.

48. The diversity of Klebsiella pneumoniae surface polysaccharides.

49. An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2.

50. Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli.

Catalog

Books, media, physical & digital resources